[144] Neuronetics, Inc. SEC Filing
Neuronetics, Inc. (STIM) filed a Form 144 reporting a proposed sale of 2,925,554 common shares, with an aggregate market value of $10,883,060.88. The filing lists Morgan Stanley Smith Barney LLC as the broker and indicates the shares are to be sold on NASDAQ with an approximate sale date of 08/08/2025.
The notice shows the shares were acquired on 12/10/2024 in connection with a Merger/Acquisition from the issuer and were paid for in cash. The filer reports nothing to report for securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Neuronetics, Inc. (STIM) ha presentato un Modulo 144 segnalando la proposta vendita di 2.925.554 azioni ordinarie, per un valore complessivo di mercato di $10.883.060,88. La documentazione indica Morgan Stanley Smith Barney LLC come broker e specifica che le azioni saranno vendute sul NASDAQ con data approssimativa di vendita il 08/08/2025.
La comunicazione riporta che le azioni sono state acquisite il 12/10/2024 in relazione a una fusione/acquisizione dall'emittente e che il corrispettivo 猫 stato pagato in contanti. Il dichiarante segnala nessuna vendita da comunicare nei tre mesi precedenti e include la dichiarazione standard di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Neuronetics, Inc. (STIM) present贸 un Formulario 144 informando la propuesta venta de 2.925.554 acciones ordinarias, con un valor de mercado agregado de $10.883.060,88. La presentaci贸n nombra a Morgan Stanley Smith Barney LLC como corredor y se帽ala que las acciones se vender谩n en el NASDAQ con una fecha aproximada de venta del 08/08/2025.
El aviso indica que las acciones fueron adquiridas el 12/10/2024 en relaci贸n con una 蹿耻蝉颈贸苍/补诲辩耻颈蝉颈肠颈贸苍 del emisor y fueron pagadas en efectivo. El declarante informa nada que declarar respecto a valores vendidos en los 煤ltimos tres meses e incluye la declaraci贸n est谩ndar de que no conoce informaci贸n adversa material no divulgada sobre el emisor.
Neuronetics, Inc. (STIM)電� 鞝滌晥霅� 毵り皝鞚� 氤搓碃頃橂姅 Form 144毳� 鞝滌稖頄堨溂氅�, 2,925,554欤� 氤错喌欤�毳� 齑� 鞁滉皜 $10,883,060.88鞐� 毵る弰頃� 鞓堨爼鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 欷戧皽鞚胳溂搿� Morgan Stanley Smith Barney LLC毳� 氇呾嫓頃橁碃 頃措嫻 欤检嫕鞚� NASDAQ鞐愳劀 鞎届爼 毵り皝鞚检澑 08/08/2025鞐� 毵る弰霅� 瓴冹澊霛缄碃 氚濏様鞀惦媹雼�.
韱奠靹滌棎 霐半ゴ氅� 頃措嫻 欤检嫕鞚� 氚滍枆鞚戈臣鞚� 顷╇硲/鞚胳垬鞕� 甏�霠晿鞐� 12/10/2024鞐� 旆摑霅橃棃鞙茧┌, 雽�旮堨潃 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵る弰頃� 歃濌秾鞐� 雽�頃� 鞁犼碃頃� 靷暛 鞐嗢潓鞚措澕瓿� 氤搓碃頄堨溂氅�, 氚滍枆鞚胳棎 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橂姅 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Neuronetics, Inc. (STIM) a d茅pos茅 un formulaire 144 signalant la proposition de vente de 2 925 554 actions ordinaires, pour une valeur marchande totale de $10鈥�883鈥�060,88. Le dossier indique Morgan Stanley Smith Barney LLC comme courtier et pr茅cise que les actions seront vendues sur le NASDAQ avec une date approximative de vente au 08/08/2025.
L'avis pr茅cise que les actions ont 茅t茅 acquises le 12/10/2024 dans le cadre d'une fusion/acquisition de l'茅metteur et ont 茅t茅 pay茅es en 别蝉辫猫肠别蝉. Le d茅clarant indique rien 脿 d茅clarer concernant des titres vendus au cours des trois derniers mois et inclut la formule habituelle selon laquelle il n'a connaissance d'aucune information d茅favorable mat茅rielle non divulgu茅e concernant l'茅metteur.
Neuronetics, Inc. (STIM) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 2.925.554 Stammaktien mit einem Gesamtmarktwert von $10.883.060,88 gemeldet wird. Die Einreichung nennt Morgan Stanley Smith Barney LLC als Broker und gibt an, dass die Aktien an der NASDAQ mit einem voraussichtlichen Verkaufstermin am 08/08/2025 ver盲u脽ert werden sollen.
Die Mitteilung weist aus, dass die Aktien am 12/10/2024 im Zusammenhang mit einer 贵耻蝉颈辞苍/脺产别谤苍补丑尘别 vom Emittenten erworben und in Bargeld bezahlt wurden. Der Einreicher berichtet f眉r die letzten drei Monate von nichts zu melden bez眉glich verkaufter Wertpapiere und enth盲lt die 眉bliche Erkl盲rung, dass ihm keine nicht offenbarten wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
- Form 144 filed to disclose proposed sale, satisfying Rule 144 reporting requirements
- Shares were acquired in a Merger/Acquisition and paid in cash on 12/10/2024
- No securities sold by the filer in the past three months ("Nothing to Report")
- Proposed sale of 2,925,554 shares (~4.43% of 66,124,820 outstanding)
- Filer CIK and certain submission contact fields appear blank in the provided content
Insights
TL;DR: Routine Rule 144 notice for ~2.93M shares; size is notable but below a common 5% materiality threshold.
The filing documents a proposed sale of 2,925,554 shares valued at $10.9 million, representing approximately 4.43% of the issuer's 66,124,820 outstanding shares. From a trading-liquidity perspective, a sale of this magnitude can add supply, but it is below the 5% threshold often used to flag materially dilutive or market-moving insider dispositions. The shares were acquired in a merger and paid in cash on 12/10/2024, and no securities sales were reported in the prior three months. Overall, this appears to be a compliant, standard Rule 144 notice rather than an exceptional corporate development.
TL;DR: Disclosure meets Rule 144 elements; lack of some filer contact identifiers in provided content is a documentation gap.
The form contains the necessary transaction details: class of security, broker, number of shares, aggregate market value, acquisition date and nature (merger/acquisition), and planned sale date. These items satisfy key Rule 144 notice elements. However, the provided content shows missing filer identifiers and contact fields, which could complicate verification if not present in the official submission. The seller's representation that no undisclosed material adverse information exists is included, aligning with the form's attestation requirements.
Neuronetics, Inc. (STIM) ha presentato un Modulo 144 segnalando la proposta vendita di 2.925.554 azioni ordinarie, per un valore complessivo di mercato di $10.883.060,88. La documentazione indica Morgan Stanley Smith Barney LLC come broker e specifica che le azioni saranno vendute sul NASDAQ con data approssimativa di vendita il 08/08/2025.
La comunicazione riporta che le azioni sono state acquisite il 12/10/2024 in relazione a una fusione/acquisizione dall'emittente e che il corrispettivo 猫 stato pagato in contanti. Il dichiarante segnala nessuna vendita da comunicare nei tre mesi precedenti e include la dichiarazione standard di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Neuronetics, Inc. (STIM) present贸 un Formulario 144 informando la propuesta venta de 2.925.554 acciones ordinarias, con un valor de mercado agregado de $10.883.060,88. La presentaci贸n nombra a Morgan Stanley Smith Barney LLC como corredor y se帽ala que las acciones se vender谩n en el NASDAQ con una fecha aproximada de venta del 08/08/2025.
El aviso indica que las acciones fueron adquiridas el 12/10/2024 en relaci贸n con una 蹿耻蝉颈贸苍/补诲辩耻颈蝉颈肠颈贸苍 del emisor y fueron pagadas en efectivo. El declarante informa nada que declarar respecto a valores vendidos en los 煤ltimos tres meses e incluye la declaraci贸n est谩ndar de que no conoce informaci贸n adversa material no divulgada sobre el emisor.
Neuronetics, Inc. (STIM)電� 鞝滌晥霅� 毵り皝鞚� 氤搓碃頃橂姅 Form 144毳� 鞝滌稖頄堨溂氅�, 2,925,554欤� 氤错喌欤�毳� 齑� 鞁滉皜 $10,883,060.88鞐� 毵る弰頃� 鞓堨爼鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 欷戧皽鞚胳溂搿� Morgan Stanley Smith Barney LLC毳� 氇呾嫓頃橁碃 頃措嫻 欤检嫕鞚� NASDAQ鞐愳劀 鞎届爼 毵り皝鞚检澑 08/08/2025鞐� 毵る弰霅� 瓴冹澊霛缄碃 氚濏様鞀惦媹雼�.
韱奠靹滌棎 霐半ゴ氅� 頃措嫻 欤检嫕鞚� 氚滍枆鞚戈臣鞚� 顷╇硲/鞚胳垬鞕� 甏�霠晿鞐� 12/10/2024鞐� 旆摑霅橃棃鞙茧┌, 雽�旮堨潃 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵る弰頃� 歃濌秾鞐� 雽�頃� 鞁犼碃頃� 靷暛 鞐嗢潓鞚措澕瓿� 氤搓碃頄堨溂氅�, 氚滍枆鞚胳棎 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橂姅 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Neuronetics, Inc. (STIM) a d茅pos茅 un formulaire 144 signalant la proposition de vente de 2 925 554 actions ordinaires, pour une valeur marchande totale de $10鈥�883鈥�060,88. Le dossier indique Morgan Stanley Smith Barney LLC comme courtier et pr茅cise que les actions seront vendues sur le NASDAQ avec une date approximative de vente au 08/08/2025.
L'avis pr茅cise que les actions ont 茅t茅 acquises le 12/10/2024 dans le cadre d'une fusion/acquisition de l'茅metteur et ont 茅t茅 pay茅es en 别蝉辫猫肠别蝉. Le d茅clarant indique rien 脿 d茅clarer concernant des titres vendus au cours des trois derniers mois et inclut la formule habituelle selon laquelle il n'a connaissance d'aucune information d茅favorable mat茅rielle non divulgu茅e concernant l'茅metteur.
Neuronetics, Inc. (STIM) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 2.925.554 Stammaktien mit einem Gesamtmarktwert von $10.883.060,88 gemeldet wird. Die Einreichung nennt Morgan Stanley Smith Barney LLC als Broker und gibt an, dass die Aktien an der NASDAQ mit einem voraussichtlichen Verkaufstermin am 08/08/2025 ver盲u脽ert werden sollen.
Die Mitteilung weist aus, dass die Aktien am 12/10/2024 im Zusammenhang mit einer 贵耻蝉颈辞苍/脺产别谤苍补丑尘别 vom Emittenten erworben und in Bargeld bezahlt wurden. Der Einreicher berichtet f眉r die letzten drei Monate von nichts zu melden bez眉glich verkaufter Wertpapiere und enth盲lt die 眉bliche Erkl盲rung, dass ihm keine nicht offenbarten wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
FAQ
What did Neuronetics (STIM) report in this Form 144?
Who is the broker handling the proposed sale for STIM?
When were the shares acquired and how were they paid for?
When is the approximate date of sale and on which exchange will STIM shares be sold?
Did the filer report any securities sold in the past three months?
